EU Drug Markets: In-depth analysis


EU Drug Markets: In-depth analysis

6 June 2022
European Monitoring Centre on Drugs and Drug Addiction (EMCDDA)

By EMCDDA and Europol

'EU Drug Markets: In-depth analysis' is a strategic and action-oriented analysis of the information available on Europe's illicit drug markets. It takes a broad view of these markets from production and trafficking, to distribution and use. It provides a holistic and systemic perspective, capturing key aspects of the wider security and public health consequences of drug markets, as well as the main factors driving change and new threats.

The analysis takes a modular format and each module focuses on the market for a particular drug — thus providing a unique set of essential resources for law enforcement professionals, policymakers, the academic community and indeed for anyone seeking up-to-date information and analysis on drug markets in Europe.

  • Cocaine
  • Methamphetamine
  • Amphetamine market (early 2023)
  • Cannabis market (early 2023)
  • Heroin market (2023)
  • MDMA market (2023)
  • NPS market (early 2023)